Literature DB >> 33871728

A Disruptive Technology: Determining Need for Permanent Pacing After TAVR.

Amneet Sandhu1,2, Wendy S Tzou3.   

Abstract

PURPOSE OF REVIEW: Transcatheter aortic valve replacement (TAVR) has changed the paradigm for management of severe aortic stenosis. Despite evolution of TAVR over the past 2 decades, conduction system disturbances remain a concern post-TAVR. In this review, we describe (1) permanent pacemaker (PP) implant rates associated with TAVR, (2) risk factors predicting need for PP therapy post-TAVR, (3) management of perioperative conduction abnormalities, and (4) novel areas of research. RECENT
FINDINGS: Conduction disturbances remain a common issue post-TAVR, in particular, left bundle branch block (LBBB). Though newer data describes resolution of a significant fraction of these disturbances over time, rates of pacemaker therapy remain high despite improvements in valve technology and procedural technique. Recent consensus statements and guideline documents are important first steps in standardizing an approach to post-TAVR conduction disturbances. New areas of research show promise in both prediction and treatment of conduction disturbances post-TAVR.

Entities:  

Keywords:  Conduction disturbances; Heart block; Permanent pacemaker; Transcatheter aortic valve replacement

Year:  2021        PMID: 33871728     DOI: 10.1007/s11886-021-01481-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  45 in total

1.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.

Authors:  Mohamed Abdel-Wahab; Julinda Mehilli; Christian Frerker; Franz-Josef Neumann; Thomas Kurz; Ralph Tölg; Dirk Zachow; Elena Guerra; Steffen Massberg; Ulrich Schäfer; Mohamed El-Mawardy; Gert Richardt
Journal:  JAMA       Date:  2014-04-16       Impact factor: 56.272

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.

Authors:  Michael J Mack; Martin B Leon; Vinod H Thourani; Raj Makkar; Susheel K Kodali; Mark Russo; Samir R Kapadia; S Chris Malaisrie; David J Cohen; Philippe Pibarot; Jonathon Leipsic; Rebecca T Hahn; Philipp Blanke; Mathew R Williams; James M McCabe; David L Brown; Vasilis Babaliaros; Scott Goldman; Wilson Y Szeto; Philippe Genereux; Ashish Pershad; Stuart J Pocock; Maria C Alu; John G Webb; Craig R Smith
Journal:  N Engl J Med       Date:  2019-03-16       Impact factor: 91.245

4.  Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.

Authors:  Makoto Mori; Syed Usman Bin Mahmood; Arnar Geirsson; James J Yun; Michael W Cleman; John K Forrest; Abeel A Mangi
Journal:  Catheter Cardiovasc Interv       Date:  2018-09-30       Impact factor: 2.692

5.  Permanent Pacemaker Implantation after TAVR - Predictors and Impact on Outcomes.

Authors:  Marcel Weber; Jan-Malte Sinning; Christoph Hammerstingl; Nikos Werner; Eberhard Grube; Georg Nickenig
Journal:  Interv Cardiol       Date:  2015-05

6.  Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Abhishek Maan; Marwan M Refaat; Edwin Kevin Heist; Jonathan Passeri; Ignacio Inglessis; Leon Ptaszek; Gus Vlahakes; Jeremy N Ruskin; Igor Palacios; Thoralf Sundt; Moussa Mansour
Journal:  Pacing Clin Electrophysiol       Date:  2015-05-28       Impact factor: 1.976

7.  Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

Authors:  Jeffrey J Popma; David H Adams; Michael J Reardon; Steven J Yakubov; Neal S Kleiman; David Heimansohn; James Hermiller; G Chad Hughes; J Kevin Harrison; Joseph Coselli; Jose Diez; Ali Kafi; Theodore Schreiber; Thomas G Gleason; John Conte; Maurice Buchbinder; G Michael Deeb; Blasé Carabello; Patrick W Serruys; Sharla Chenoweth; Jae K Oh
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

8.  One year follow-up of the multi-centre European PARTNER transcatheter heart valve study.

Authors:  Thierry Lefèvre; Ari Pieter Kappetein; Ernst Wolner; Patrick Nataf; Martyn Thomas; Volker Schächinger; Bernard De Bruyne; Hélène Eltchaninoff; Matthias Thielmann; Dominique Himbert; Mauro Romano; Patrick Serruys; Gerhard Wimmer-Greinecker
Journal:  Eur Heart J       Date:  2010-11-12       Impact factor: 29.983

9.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

Review 10.  Rate and Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation: Current Status.

Authors:  Eleonora Russo; Domenico R Potenza; Michela Casella; Raimondo Massaro; Giulio Russo; Maurizio Braccio; Antonio Dello Russo; Mauro Cassese
Journal:  Curr Cardiol Rev       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.